CDC Website CDC Website

To Join the NPIN community or

Home » Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional)

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional)

The purpose of this funding opportunity is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and SUD mechanistic research.

Application Due Date
10/25/21
Project Start Date
7/1/22
Application Contact
Cheryl
Nathaniel
Grants Management Specialist
301-827-6703
cnathanic@nih.gov
Technical Contact
Jonathan D.
Pollock, Ph.D
Branch Chief, Genetics, Epigenetics, and Developmental Neuroscience
jpollock@mail.nih.gov
301-435-1309
Subjects
Audiences

Fund Number: 

354694

Fund ID: 

RFA-DA-22-010

Last modified: 

3/2/21